Riskpilot← Back to searchSign inGet full accessSerodus ApS
APSActiveCVR 31888263Ole Maaløes Vej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 20081 employeeswww.serodus.com
Revenue 2024
DKK 818K
+16% vs 2023
EBITDA margin
-86.7%
-30% vs 2023
Equity ratio
91.6%
Financial strength
Net profit 2024
DKK -713K
-30% vs 2023
| Revenue | DKK 818K | +16% |
| EBITDA | DKK -710K | -30% |
| Net profit | DKK -713K | -30% |
| Total assets | DKK 1,7M | -30% |
| Equity | DKK 1,5M | -32% |
| Employees | 1 | — |
Legal name
Serodus ApS
CVR number
31888263
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18. december 2008
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af bestyrelsesformanden og den administrerende direktør i forening.
Company purpose
Selskabets formål er at drive virksomhed gennem forskning og udvikling af lægemidler til behandling af sukkersyge og beslægtede sygdomme. Desuden yder selskabet konsulentbistand indenfor udvikling af lægemidler og administration af kliniske studier, samt hermed forbundet virksomhed.
Address
Ole Maaløes Vej 3
Phone
+4521652136
Email
henrik.mordhorst@serodus.com
Website
www.serodus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -227 | 825 | — | -1.564 | -1.122 | -496 | -207 | -214 | -1.259 | -1.808 | -351 | 705 | 818 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1.252 | -1.528 |
| EBITDA | -227 | 825 | 0 | -1.564 | -1.122 | -496 | -207 | -214 | -1.259 | -1.808 | -351 | -547 | -710 |
| Depreciation & amort. | 5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -232 | 825 | 0 | -1.564 | -1.122 | -496 | -207 | -214 | -1.259 | -1.808 | -351 | -547 | -710 |
| Net financials | -1 | -57 | 0 | 48 | -71 | 113 | -9 | -5 | -31 | -114 | -17 | -2 | -3 |
| Profit before tax | — | 769 | 0 | -1.517 | -1.193 | -383 | -216 | -219 | -1.290 | -1.922 | -368 | -549 | -713 |
| Tax | -0 | -0 | -0 | -217 | -84 | -58 | -0 | -0 | -0 | -484 | -0 | -0 | -0 |
| Net profit | -233 | 769 | 0 | -1.300 | -1.110 | -325 | -216 | -219 | -1.290 | -1.438 | -368 | -549 | -713 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 177 | 2.599 | 0 | 1.487 | 807 | 251 | 284 | 310 | 613 | 3.208 | 2.832 | 2.424 | 1.685 |
| Equity | — | 1.967 | 0 | 160 | -950 | -1.275 | 1 | -219 | -1.139 | -2.577 | 2.804 | 2.255 | 1.542 |
| Long-term debt | 0 | 0 | 0 | 0 | 1.271 | 1.491 | 248 | 493 | 515 | 5.749 | 0 | 0 | 0 |
| Short-term debt | 12 | -633 | 0 | 1.328 | 486 | 34 | 36 | 36 | 1.237 | 36 | 28 | 169 | 142 |
| Total debt | 12 | -633 | 0 | 1.328 | 1.757 | 1.525 | 284 | 528 | 1.752 | 5.785 | 28 | 169 | 142 |
EBITDA margin
-86.7%
This company
15.8%
Market median
-649% vs market
20122024
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20122024
Return on equity
-46.2%
This company
18.4%
Market median
-351% vs market
20122024
Net profit margin
-87.1%
This company
8.1%
Market median
-1175% vs market
20122024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20122024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ES Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
TF Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Serodus ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Steiness | Chief Executive Officer | 0 companies |
| Torben Frank Skarsfeldt | Chief Executive Officer | 0 companies |
| Lars Beck-Thomsen | Board of Directors | 0 companies |
| Viggo Gunnersen Harboe | Board of Directors | 0 companies |
| Søren Elmann Ingerslev | Chairman | 0 companies |
| Arnstein Gunnestad Endresen | Board of Directors | 0 companies |
| Elisabeth Marianne Bock | Board of Directors | 0 companies |
| Volodymyr Berezin | Board of Directors | 0 companies |